Skip to main content
. Author manuscript; available in PMC: 2023 Oct 3.
Published in final edited form as: Clin Cancer Res. 2017 May 11;23(14):3566–3574. doi: 10.1158/1078-0432.CCR-16-2900

Table 2.

Patient serologic responses to single dose of intratumoral HSV1716.

Patient WBC ALC ANC HSV-1 PCR HSV-1 IgG
Day 0 0 0 0 and 1 4 7 14 21 28 Baseline 28
HSV01 4.9 686 3626 - - - - - - - +
HSV02 4.7 1739 1692 - - - - - - + +
HSV03 6 1140 4140 - + - - - - - +
HSV04 3 600 2040 - + + + + + - +
HSV05 4.4 1408 2640 - - - - - - - -
HSV06 8 1040 5600 - + - - - - - -
HSV07 6 1260 4080 - + - - - - - ND
HSV08 4.3 1419 2451 - + - - - - - +
HSV09 6.1 1769 3721 - + + - - - - +

WBC = white blood cell count, ALC = absolute lymphocyte count, ANC = absolute neutrophil count, ND = not done.